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Abstract
Background: The prevalence of anxiety and depressive disorders in cancer patients and its associated factors in
Pakistan is not known. There is a need to develop an evidence base to help introduce interventions as untreated
depression and anxiety can lead to significant morbidity. We assessed the prevalence of depression and anxiety
among adult outpatients with and without cancer as well as the effect of various demographic, clinical and
behavioral factors on levels of depression and anxiety in cancer patients.
Methods: This cross-sectional study was carried out in outpatient departments of Multan Institute of Nuclear
Medicine and Radiotherapy and Nishtar Medical College Hospital, Multan. Aga Khan University Anxiety and
Depression Scale (AKUADS) was used to define the presence of depression and anxiety in study participants. The
sample consisted of 150 diagnosed cancer patients and 268 participants without cancer (control group).
Results: The mean age of cancer patients was 40.85 years (SD = 16.46) and median illness duration was 5.5
months, while the mean age of the control group was 39.58 years (SD = 11.74). Overall, 66.0% of the cancer
patients were found to have depression and anxiety using a cutoff score of 20 on AKUADS. Among the control
group, 109 subjects (40.7%) had depression and anxiety. Cancer patients were significantly more likely to suffer
from distress compared to the control group (OR = 2.83, 95% CI = 1.89-4.25, P = 0.0001). Performing logistic
regression analysis showed that age up to 40 years significantly influenced the prevalence of depression and
anxiety in cancer patients. There was no statistically significant difference between gender, marital status, locality,
education, income, occupation, physical activity, smoking, cancer site, illness duration and mode of treatment,
surgery related to cancer and presence of depression and anxiety. Cancers highly associated with depression and
anxiety were gastrointestinal malignancies, chest tumors and breast cancer.
Conclusions: This study highlights high prevalence rates of depression and anxiety in cancer patients. Younger
age was associated with a higher likelihood of meeting criteria for psychological morbidity. The findings support
screening patients for symptoms of depression and anxiety as part of standard cancer care and referring those at a
higher risk of developing psychological morbidity for appropriate care.
Background
Cancer is a serious and potentially life-threatening ill-
ness which has an effect on physical and emotional well
being of patients and their families. The diagnosis of
cancer is a stressful event causing significant psychologi-
cal distress [1-4]. In this era of improved cancer care, it
is still often believed that pain and death is inevitable
for cancer patients [5].
Various studies have demonstrated high levels of
depression and anxiety in cancer patients using a variety
of assessment methods [1,3,4,6-8]. Depression is a chal-
lenge to study in cancer patients as symptoms occur over
a range of spectrum being different in different patients
[ 4 , 9 ] .I ti sac h a l l e n g i n gj o bt od i a g n o s ed e p r e s s i o ni n
patients with cancer. It may present with guilt, worthless-
ness, hopelessness, lowered self esteem, social withdrawal
or suicidal preoccupation [9,10]. This is further compli-
cated by the findings that symptoms in cancer patients
occur in clusters [11]. Anxiety has been shown to fre-
quently coexist with depressive disorders [6-9]. This is
significant as it has been shown that patients with comor-
bid anxiety and depressive disorders tend to have severe
symptoms, longer recovery times, poorer outcomes and
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any medium, provided the original work is properly cited.greater use of healthcare resources than those with a sin-
gle disorder [12]. Prevalence and severity of psychological
distress also vary across cancer types [3,4]. Anxiety and
depression in cancer patients may be caused by various
reasons including psychological reaction caused by diag-
nosis of cancer, long duration of treatment, side effects of
treatment, repeated hospitalizations, disruption in life
and diminished quality of life [6,13,14]. Furthermore,
some of the agents act directly on central nervous system
causing psychiatric morbidity [15].
Despite all these findings of higher likelihood of can-
cer patients to suffer from psychological distress, studies
have reported that healthcare workers fail to identify
cancer patients with depression and anxiety leading to
under-treatment in 40-90% of the cases [10,16,17]. It is
important to recognize depression in cancer patients
because it may reduce chances of survival and predict
early mortality [18,19]. Presence of depression and anxi-
ety produces complications in treatment of both cancer
and depression and can lead to poor compliance with
treatment resulting in worsening of situation. It puts the
patients at a higher risk of suicide and may produce a
desire for hastened death [20]. Depression leads to a
decline in patient satisfaction with medical care and pre-
dicts disease progression [21,22]. Psychological distress
also has a negative effect on quality of life [23]. Depres-
sion and anxiety impair quality of life not only of the
patients but also of their caregivers [24,25]. Research
suggests that interventions to treat depression and anxi-
ety are effective even in patients with advanced disease
[13,26]. In addition, identification and treatment of
depression and anxiety leads to reduction in disease pro-
gression improvement in survival rates, reduction in
healthcare costs and improvement in quality of life
[18,19,22,23,27].
T h e r ei san e e dt od e v e l o pa ne v i d e n c eb a s et oh e l p
introduce interventions as untreated depression and
anxiety can lead to significant morbidity. We need pre-
valence estimates to be able to develop an effective
strategy. Although there are a number of studies asses-
sing psychological distress in cancer patients, there are
significant gaps in literature. Majority of studies have
not used a control group. This may limit generalizability
of such studies due to recruitment bias. Furthermore,
we have not been able to find studies investigating the
association of various demographic, behavioural and
clinical factors with the prevalence of depression and
anxiety in cancer patients. Such studies are needed so as
to identify subgroups needing intervention. Finally, there
is paucity of studies on psychological distress in cancer
patients from this region. There is only one study on
t h ep r e v a l e n c eo fd e p r e s s i o na n da n x i e t yf r o mP a k i s t a n
which employs a small sample size from a single centre
with no control group [28]. This is the first multi-centre
study from Pakistan with adequate number of patients
reporting the prevalence of depression and anxiety in
adult cancer outpatients. This paper outlines the results
of a cross-sectional study carried out in the outpatient
departments of Multan Institute of Nuclear Medicine
and Radiotherapy (MINAR) and Nishtar Medical Col-
lege Hospital, Multan (NMCH). The main objective of
our study was to determine the prevalence of depression
and anxiety in patients with cancer using a validated
and reliable screening instrument and to compare them
with the patients visiting medical outpatient department.
We also wanted to find out the relationship of depres-
sion and anxiety with age, gender, locality, education,
income and occupation, type of cancer, current treat-
ment modality, duration of illness and history of surgical
intervention related to the disease, smoking and physical
activity.
Methods
A multi-centre, cross-sectional study was carried out in
the outpatient departments of MINAR and NMCH,
Multan to determine the prevalence of depression and
anxiety in adult cancer outpatients. Consecutive patients
visiting outpatient department were recruited for the
study. Patients were included if they had a cancer diag-
nosis, were in the age range 18-70 years, consented to
participate in the study, and were able to complete
questionnaire. Exclusion criteria were diagnosis at cur-
rent visit, critical condition, language or hearing pro-
blem, cognitive impairment, incomplete records or
ongoing psychological treatment. The authors
approached all the eligible patients and requested their
consent to participate in the study after explaining the
study. Controls were randomly selected from different
outpatient departments of the same centres to reduce
potential differences in socioeconomic and educational
factors. Every fifth patient visiting the medical outpatient
department was recruited in the study after taking
informed consent.
Anxiety and depression were assessed using a self
administered structured questionnaire. The question-
naire was administered after taking written informed
consent from the participants. Data on basic demo-
graphic details including age, gender, locality, education,
income and occupation were collected. Cancer related
variables including type of cancer, current treatment
modality, duration of illness and history of surgical
intervention related to the disease were obtained from
the medical record of the patients. Behavioral factors
included in the questionnaire to determine their associa-
tion with depression and anxiety were smoking and phy-
sical activity which were self reported. Patients were
labelled smokers if they had smoked for more than one
year. Physical activity was defined as exercise for more
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assessed using Aga Khan University Anxiety and
Depression Scale (AKUADS). It is a 25-item self admi-
nistered instrument that measures the presence of
symptomatology of anxiety and depression in adults. It
is a widely used instrument developed indigenously in
Urdu. Its validation study has shown that it is a reliable
and valid instrument to assess psychological morbidity
in patients. It has 13 psychological and 12 somatic items
which measure presence and severity of symptoms mak-
ing it superior to other available instruments in Urdu
containing only either psychological or somatic items
[29,30]. At a cut-off score of 20, it has a sensitivity of
66%, a specificity of 79%, a positive predictive value of
83 and a negative predictive value of 60. It has a good
level of reliability and analysis showed item-item corre-
lation ≥ 0.75 [29,30]. The data from the questionnaire
was entered as categorical data on the basis of cutoff for
analysis.
Data was analyzed using Statistical Package for Social
Sciences 16 (SPSS Inc., Chicago, IL, USA). Descriptive
analyses were recorded as means and proportions.
Logistic regression analysis was employed to determine
the association of various demographic, clinical and
behavioral factors with the presence of depression and
anxiety in cancer patients. A p value of < 0.05 was con-
sidered statistically significant.
The study was approved by ethics review committee
of NMCH, Multan. Written informed consent was
obtained from all the participants accrued in the study.
Results
O u to fat o t a lo f2 0 0c a n c e rp a tients selected, 186 were
determined to be eligible for survey. Fourteen patients
were ineligible on account of diagnosis on recent visit (4),
critical condition (1), cognitive impairment (4), language
problem (2) or ongoing psychiatric treatment (3). With a
response rate of 90.9%, 169 patients consented to partici-
pate in the study and completed questionnaires. After
excluding incompletely filled questionnaires, 150 partici-
pants were included in final analysis. The mean age of
cancer patients was 40.85 years (SD = 16.46 years) and
median duration of illness was 5.50 months. Majority of
the patients were male (64.0%), married (79.3%), from
urban locality (53.3%), illiterate (44.0%), belonging to low
socioeconomic group (66.7%), and unemployed (29.3%).
Most of the patients were non-smokers (71.3%) and phy-
sically active (56.0%). The most common diagnoses were
urological (21.3%), hematological (18.0%), and head and
neck malignancies (15.0%) and breast (14.0%) cancer. A
control group of 300 individuals was selected out of
which 293 were eligible for accrual. In total, 281 subjects
consented and filled the study questionnaire with a
response rate of 95.9%. Control subjects included in the
Table 1 Participant Characteristics
Variables Cancer Subjects
No. (%)
Control Subjects
No. (%)
Age
≤ 40 Years 78(52.0) 166(61.9)
> 40 Years 72(48.0) 102(38.1)
Gender
Male 96(64.0) 158(59.0)
Female 54(36.0) 110(41.0)
Marital Status
Married 119(79.3) 193(72.0)
Unmarried 31(20.7) 75(28.0)
Locality
Urban 80(53.3) 139(51.9)
Rural 70(46.7) 129(48.1)
Education
Illiterate 60(40.0) 80(29.9)
Primary 19(12.7) 42(15.7)
Secondary 31(20.7) 68(25.4)
High School Certificate 19(12.7) 40(14.9)
Bachelor 17(11.3) 23(8.6)
Masters 4(2.7) 15(5.6)
Income
< Rs. 10,000 100(66.7) 147(54.9)
Rs.10,000-Rs.20,000 41(27.3) 50(18.7)
Rs.20,000-Rs.40,000 6(4.0) 43(16.0)
> Rs. 40,000 3(2.0) 28(10.4)
Occupation
Professional 13(8.7) 20(7.5)
Skilled worker 10(6.7) 29(10.8)
Administrative Job 11(7.3) 23(8.6)
Sales 19(12.7) 55(20.5)
Farming 24(16.0) 12(4.5)
Unskilled/Elementary 29(19.3) 31(11.6)
Unemployed 44(29.3) 98(36.6)
Physical Activity
Active 84(56.0)
Inactive 66(44.0)
Smoking
Smoker 43(28.7)
Non-Smoker 107(71.3)
Cancer
Hematological 27(18.0)
Head & Neck 23(15.3)
Urological 32(21.3)
Breast 21(14.0)
Chest 13(8.7)
Sarcoma 11(7.3)
Squamous & Basal Cell 1(0.7)
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questionnaires. The mean age of control group was 39.58
years (SD = 11.74 years). Demographics and clinical char-
acteristics of cancer subjects are presented in table 1
along with demographics of control group. Since the con-
trol group accrual was done from waiting rooms of medi-
cal outpatient department, data about their diagnoses is
not available.
Overall, 66.0% of the cancer patients were found to
have depression and anxiety using a cut-off score of 20
on AKUADS. Among the control group, 109 subjects
(40.7%) had depression and anxiety. This difference in
the prevalence rates was found to be statistically signifi-
cant (p < 0.001). Cancer patients were 2.83 times more
likely to have psychological distress (95% CI = 1.89-
4.25). Cancers with the highest prevalence of depression
and anxiety were gastrointestinal malignancies, chest
tumors and breast cancer.
Table 2 describes the results of logistic regression ana-
lysis performed for determining the association of var-
ious demographic, clinical and behavioral factors with
the presence of depression and anxiety in cancer
patients. Age less than 40 years was found to signifi-
cantly increase the odds of having depression and anxi-
ety among cancer patients. The findings showed that
among different demographic variables, there were no
significant differences among anxiety, depression and
patients’ gender, marital status, locality, educational
background, socioeconomic status, and occupation. The
results also indicated that type of malignancy, duration
of illness, type of intervention and surgery related to dis-
ease did not significantly alter the odds of having
depression and anxiety. Finally among behavioral fac-
tors, both smoking and physical activity did not signifi-
cantly alter the odds of suffering from depression and
anxiety.
Table 2 The Results of Logistic Regression Analysis
showing association of variables with Psychological
distress in cancer patients
Variables OR 95% CI P
Age 0.027
≤40 Years 1
>40 Years 0.46 0.23-0.91
Gender 0.900
Male 1
Female 1.05 0.52-2.12
Marital Status 0.297
Married 1
Unmarried 0.65 0.29-1.46
Locality 0.534
Urban 1
Rural 1.24 0.63-2.45
Education 0.727
Illiterate 1
Primary 0.5 0.07-3.81
Secondary 0.27 0.03-2.53
High School Certificate 0.63 0.08-5.10
Bachelors 0.73 0.08-6.31
Masters 0.05-3.84
Income 0.641
<Rs. 10,000 1
Rs.10,000-Rs.20,000 0.27 0.02-3.08
Rs.20,000-Rs.40,000 0.21 0.02-2.5
>Rs. 40,000 0.25 0.01-4.73
Occupation 0.714
Professional 1
Skilled worker 0.48 0.12-1.98
Administrative Job 0.68 0.15-2.99
Sales 1.91 0.50-7.23
Farming 0.57 0.17-1.86
Unskilled/Elementary 0.79 0.28-2.25
Unemployed 0.72 0.27-1.93
Physical Activity 0.397
Active 1
Inactive 1.35 0.68-2.67
Smoking 0.082
Smoker 1 0.747
Non-Smoker 0.49 0.22-1.00
Cancer 0.144
Hematological 1
Head & Neck 7.0 1.32-37.15
Urological 3.47 0.62-19.33
Breast 3.9 0.75-20.34
Chest 2.03 0.34-12.24
Table 1 Participant Characteristics (Continued)
Brain 7(4.7)
GIT 15(10.0)
Duration
≤6 Months 88(58.7)
>6 Months 62(41.3)
Treatment
Chemotherapy 55(36.7)
Radiotherapy 22(14.7)
Concomitant 59(39.3)
None 14(9.3)
Surgery
Yes 63(42.0)
No 87(58.0)
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The main finding of this study is the high prevalence of
depression and anxiety in cancer patients as compared
to the control group (66.0% vs. 40.7%). In our study,
66% patients with cancer had depression and anxiety.
This is slightly higher than some studies conducted ear-
lier which reported prevalence of depression spectrum
syndromes ranging from 0-58% [1,3,4]. However, the
findings are comparable to a recent study from Pakistan
reporting prevalence rates of 52% in cancer patients and
a study from Iran showing rates of 47.2% and 57% for
depression and anxiety respectively [28,31]. There can
be a number of reasons for this difference in prevalence
rates. A first explanation could be that most of the stu-
dies on prevalence of psychological morbidity in cancer
patients are from developed countries which have low
prevalence of mental health problems as compared to
developing countries [32]. A second explanation could
be that prevalence of psychological morbidity even in
general population of Pakistan is much higher, as docu-
mented by a systematic review reporting prevalence rate
of 34% in general population which is close to the level
of psychological morbidity in control group in our study
[33]. A third explanation could be that many of the par-
ticipants in our study were from rural areas, illiterate,
and had a low household income which is established
risk factors for psychiatric morbidity [28]. Also the pre-
vailing situation in the country puts them at even higher
risk as country is facing socio-political instability, eco-
nomic crises and growing unemployment.
This is the first study to our knowledge from Pakistan
reporting depression and anxiety in cancer patients
from two centres with a control group using a valid and
reliable instrument. In our study, a significant associa-
tion was observed between psychological morbidity and
age with patients of age up to 40 years having a higher
likelihood of suffering from depression and anxiety. This
is in agreement with previous studies demonstrating
that younger people are more prone to psychological
distress when suffering from cancer [31,34,35].
There was no statistically significant relationship
between depression, anxiety and various demographic
factors in the present study. A meta-analysis of 58 stu-
dies showed that there were significant differences
among groups with regards to sex, age and type of can-
cer [36]. We, however, did not find any significant effect
of gender on predisposition to psychological morbidity.
Marital status, locality, education, income, and occupa-
tion also did not affect psychological morbidity presence
in our study. In addition, there was no significant asso-
ciation of depression and anxiety with cancer type, dura-
tion, treatment, or surgery related to disease. A study
from Japan, however, reported increased levels of
depression in cancer patients undergoing surgery [37].
Strengths of our study include standardized measures,
use of control group, analysis of factors that may affect
prevalence of depression and anxiety and a good
response rate. The goal of unbiased control was
achieved by recruiting both cases and controls at the
same time and under same conditions. Furthermore,
both the cases and controls were from the same source
population and were evaluated using the same instru-
ment. We used a valid and reliable questionnaire devel-
oped indigenously in Urdu to reduce the potential of
error caused by instruments developed from populations
belonging to different cultural and socioeconomic set-
ups. The study also has certain limitations including use
of self reported questionnaires instead of diagnostic
interview and unavailability of diagnosis for the control
group.
In order to provide optimum care for cancer patients
incorporating management of physical as well as psy-
chological symptoms, it is necessary to increase aware-
ness about prevalence of psychological morbidity among
cancer patients and improve identification of symptoms
[9]. It is recommended that all the cancer patients
should complete a psychological screening on baseline
as a part of standard cancer care. The oncologist should
then refer the patients for appropriate care on the basis
of results of screening. The concern expressed by some
clinicians of bothering patients is unfounded as most of
the patients are thankful for the opportunity to answer
questions about their feelings [38]. It has been demon-
strated that even a short psychological intervention
delivered by nonspecialist is effective and promotes
adjustment among cancer patients at a high risk of
developing depression and anxiety [26,39]. This has also
Table 2 The Results of Logistic Regression Analysis show-
ing association of variables with Psychological distress in
cancer patients (Continued)
Sarcoma 5.42 0.04-60.77
Squamous & Basal Cell 5.41 0.81-36.36
Brain 1.24 0.23-6.62
GIT 8.67 1.05-71.57
Duration 0.747
≤ 6 Months 1
> 6 Months 1.12 0.56-2.22
Treatment 0.995
Chemotherapy 1
Radiotherapy 0.95 0.28-3.24
Concomitant 0.84 0.20-3.46
None 0.92 0.27-3.12
Surgery 0.234
Yes 1
No 0.66 0.33-1.32
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lines which recommend screening of patients for dis-
tress and psychotherapy subsequently for those with
moderate to severe distress [2,40].
Conclusions
The study shows that compared with control group,
adults with cancer have higher prevalence rates of
depression and anxiety. Younger age was associated
with a higher likelihood of meeting criteria for psycholo-
gical morbidity. The findings support screening patients
for symptoms of depression and anxiety as part of stan-
dard cancer care and referring those at a higher risk of
developing psychological morbidity for appropriate care.
This will lead to decreased morbidity, improvement in
disease outcome, reduction in healthcare costs, and
improvement in quality of life of patients.
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